Progressive retinal degeneration in transgenic mice with overexpression of endothelin-1 in vascular endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4842-4851

  Mi, Xue Song ^a   Zhang, Xu ^a   Feng, Qian ^a   Lo, Amy Cheuk Yin ^c   Chung, Sookja Kim ^a   So, Kwok Fai ^a,b,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; OCCLUDIN;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; ASTROCYTE; CELL LOSS; CONTROLLED STUDY; FEMALE; HISTOLOGY; IMMUNOCYTOCHEMISTRY; INTRAOCULAR PRESSURE; MALE; MOUSE; MUELLER CELL; NERVE DEGENERATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BIPOLAR GANGLION CELL; RETINA BLOOD VESSEL; RETINA DEGENERATION; RETINA GANGLION CELL; RETINAL NERVE FIBER LAYER THICKNESS; TRANSGENIC MOUSE; WESTERN BLOTTING; AGING; ANIMAL; ENDOTHELIUM CELL; METABOLISM; NERVE FIBER; PATHOLOGY; RETINA;

AGING; ANIMALS; AXONS; BLOTTING, WESTERN; ENDOTHELIAL CELLS; ENDOTHELIN-1; IMMUNOGLOBULIN G; INTRAOCULAR PRESSURE; MICE; MICE, TRANSGENIC; RETINA; RETINAL DEGENERATION; RETINAL GANGLION CELLS;

EID: 84867290614     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9999     Document Type: Article

References (56)

1. McKinnon SJ. Glaucoma: ocular Alzheimer's disease. Front Biosci. 2003;8:s1140-s1156.
2. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.
3. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641-1648.
4. Cursiefen C, Wisse M, Cursiefen S, Jünemann A, Martus P, Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol. 2000;129:102-104.
5. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma. 2002; 11:259-270.
6. Cellini M, Possati G, Profazio V, Sbrocca M, Caramazza N, Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol Scand. 1997;75:11-13.
7. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies*. Surv Ophthalmol. 1995;39:S49-S56.
8. Emre M, Orgül S, Haufschild T, Shaw SG, Flammer J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005;89:60-63.
9. Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52:S144-S154.
10. Galassi F, Giambene B, Varriale R. Systemic vascular dysregulation and retrobulbar hemodynamics in normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2011;52:4467-4471.
11. Orgül S, Cioffi GA, Bacon DR, Van Buskirk EM. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma. 1996;5:135-138.
12. Nagano H, Wei PZ, Wen CQ, et al. Effects of kallidinogenase on ischemic changes induced by repeated intravitreal injections of endothelin-1 in rabbit retina. Curr Eye Res. 2007;32:113-122.
13. Taniguchi T, Shimazawa M, Sasaoka M, Shimazaki A, Hara H. Endothelin-1 impairs retrograde axonal transport and leads to axonal injury in rat optic nerve. Curr Neurovasc Res. 2006;3: 81-88.
14. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144-152.
15. Lau J, Dang M, Hockmann K, Ball AK. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Exp Eye Res. 2006;82:132-145.
16. Sasaoka M, Taniguchi T, Shimazawa M, Ishida N, Shimazaki A, Hara H. Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits. Exp Eye Res. 2006;83:629-637.
17. Leung JWC, Ho MCY, Lo ACY, Chung SSM, Chung SK. Endothelial cell-specific over-expression of endothelin-1 leads to more severe cerebral damage following transient middle cerebral artery occlusion. J Cardiovasc Pharmacol. 2004; 44(suppl 1):S293-S300.
18. Leung JWC, Chung SSM, Chung SK. Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res. 2009;1266:121-129.
19. Li SY, Fu ZJ, Ma H, et al. Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest Ophthalmol Vis Sci. 2009;50:836-843.
20. Cheung AKH, Lo ACY, So KF, Chung SSM, Chung SK. Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury. Exp Eye Res. 2007;85: 608-616.
21. Cui Q, Hodgetts S, Hu Y, Luo JM, Harvey A. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats. Neuroscience. 2007;146:986-999.
22. Chen H, Wei X, Cho KS, et al. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. Invest Ophthalmol Vis Sci. 2011;52:36-44.
23. Fu QL, Hu B, Wu W, Pepinsky RB, Mi S, So KF. Blocking LINGO1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Invest Ophthalmol Vis Sci. 2008;49:975-985.
24. Li S-Y, Yang D, Yeung C-M, et al. Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury. PloS ONE. 2011;6:e16380.
25. Mori A, Saigo O, Hanada M, Nakahara T, Ishii K. Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats. J Pharmacol Sci. 2009;110: 160-168.
26. Taylor AC, Seltz LM, Yates PA, Peirce SM. Chronic whole-body hypoxia induces intussusceptive angiogenesis and microvascular remodeling in the mouse retina. Microvasc Res. 2010;79:93-101.
27. Chacón M, Barria M, Lorca R, Huidobro-Toro J, Inestrosa N. A human prion protein peptide (PrP(59-91)) protects against copper neurotoxicity. Mol Psychiatry. 2003;8:853-862.
28. Aihara M, Lindsey JD, Weinreb RN. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res. 2003;77:681-686.
29. Cheung SS, Leung JW, Lam AK, et al. Selective over-expression of endothelin-1 in endothelial cells exacerbates inner retinal edema and neuronal death in ischemic retina. PLoS ONE. 2011;6:e26184.
30. Cheung AKH, Fung MKL, Lo ACY, et al. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes. 2005;54:3119-3125.
31. Leung JW, Wong WT, Koon HW, et al. Transgenic mice overexpressing ET-1 in the endothelial cells develop systemichypertension with altered vascular reactivity. PLoS ONE. 2011; 6:e26994.
32. Shields MB. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol. 2008; 19:85-88.
33. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol. 1974;13:455-457.
34. Quigley HA. Glaucoma. Lancet. 2011;377:1367-1377.
35. John S, Smith RS, Savinova OV, et al. Essential iris atrophy,pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
36. Harada T, Harada C, Nakamura K, et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest. 2007;117:1763-1770.
37. Chi ZL, Akahori M, Obazawa M, et al. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol Genet. 2010;19:2606-2615.
38. Chi ZL, Yasumoto F, Sergeev Y, et al. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice. Hum Mol Genet. 2010;19:3806-3815.
39. Shah R, Wormald RP. Glaucoma. Clin Evid (Online). 2011;Jun 9:2011.
40. Kniestedt C, Lin S, Choe J, et al. Correlation between intraocular pressure, central corneal thickness, stage of glaucoma, and demographic patient data: prospective analysis of biophysical parameters in tertiary glaucoma practice populations. J Glaucoma. 2006;15:91-97.
41. Wang X, LeVatte TL, Archibald ML, Chauhan BC. Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic experimental optic neuropathy. Exp Eye Res. 2009;88:378-385.
42. Schwartz B. Circulatory defects of the optic disk and retina in ocular hypertension and high pressure open-angle glaucoma. Surv Ophthalmol. 1994;38(suppl):S23-S34.
43. Grieshaber MC, Flammer J. Does the blood-brain barrier play a role in glaucoma? Surv Ophthalmol. 2007;52:S115-S121.
44. Heiduschka P, Julien S, Schuettauf F, Schnichels S. Loss of retinal function in aged DBA/2J mice: new insights into retinal neurodegeneration. Exp Eye Res. 2010;91:779-783.
45. Kanis MJ, Lemij HG, Berendschot TTJM, van de Kraats J, van Norren D. Foveal cone photoreceptor involvement in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010;248:999-1006.
46. Zhao Z, Chen Y, Wang J, et al. Age-related retinopathy in NRF2deficient mice. PLoS ONE. 2011;6:e19456.
47. Tang Y, Li X, Li Y, et al. Renovascular hypertension causes cerebral vascular remodeling. Neural Regen Res. 2011;6: 1977-1981.
48. Lo ACY, Chen AYS, Hung VKL, et al. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J Cereb Blood Flow Metab. 2005;25:998-1011.
49. Yeung PKK, Lo ACY, Leung JWC, Chung SSM, Chung SK. Targeted overexpression of endothelin-1 in astrocytes leads to more severe cytotoxic brain edema and higher mortality. J Cereb Blood Flow Metabolism. 2009;29:1891-1902.
50. Makanya AN, Hlushchuk R, Djonov VG. Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling. Angiogenesis. 2009;12:113-123.
51. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging. 2009;30:337-352.
52. Prasanna G, Krishnamoorthy R, Clark AF, Wordinger RJ, Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002;43:2704-2713.
53. Murphy JA, Archibald ML, Chauhan BC. The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation. Br J Ophthalmol. 2010;94:1233-1238.
54. Mansour H, Chamberlain CG, Weible I, et al. Aging-related changes in astrocytes in the rat retina: imbalance between cell proliferation and cell death reduces astrocyte availability. Aging Cell. 2008;7:526-540.
55. Torbidoni V, Iribarne M, Ogawa L, Prasanna G, Suburo AM. Endothelin-1 and endothelin receptors in light-induced retinal degeneration. Exp Eye Res. 2005;81:265-275.
56. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol. 2008;86:380-393.